CytoReason
Tel Aviv
About CytoReason
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data. The company collects proprietary data from pharma companies and uses it to simulate human diseases tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of approval.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $100.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2024)
- Website: cytoreason.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/cytoreason-114164 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.